MTM1 and X-linked myotubular myopathy: Furthermore, three cases of severe hepatobiliary disease were recently documented in patients with X-linked myotubular myopathy (XLMTM), who received a high dose (3 × 1014 genome copies/kg) of AAV8 expressing the therapeutic MTM1 gene [118].